FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

GW Pharma to test cannabis as obesity therapy

Tools

GW Pharmaceuticals is planning to start human trials of a new obesity treatment derived from cannabis. A variety of drug developers, including Sanofi-Aventis, are working to develop therapies that snap the body's craving for food when they smoke cannabis. And researchers at the U.K. company say that cannabis itself contains clues to controlling obesity. Various ingredients in cannabis, they say, can both stimulate and suppress hunger.

- here's the report from MedIndia

Related Articles:
Solvay earns $25M as obesity drug advances. Report
EMEA committee recommends Acomplia of obesity. Report
FDA approves synthetic cannabis. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Solvay Pharmaceuticals   Sanofi-Aventis   obesity   FDA   acomplia  

Comments

How is stopping people from not eating going to make them healthy? If people aren't eating they will not be getting the nutrition they need to function throughout the day. Eating healthy and exercise are the cure for obesity. Taking a drug to get skinny won't help combat obesity, it will just temporarily solve the problem. Exercise and a healthy diet will take care of the problem.

Drug Addiction Treatment Center

That's exactly what it says. It moderates your appetite, i don't think they don't want them to eat.

I have long suspected that cannabis is an appetite modulator. Yes, food may taste better when one is stoned, but it also satisfies more, and eating becomes a "conscious activity" rather than a mindless face-stuffing session.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.